TD Cowen Maintains Takeda Pharmaceutical(TAK.US) With Buy Rating, Announces Target Price $16
Analysts Offer Insights on Healthcare Companies: Lineage Therap (LCTX), Veeva Systems (VEEV) and Takeda Pharmaceutical Company (TAK)
Chordia Research Memo (2): Spun out from takeda pharmaceuticals sp adr, focusing on the development of anticancer drugs.
■Company overview of Chordia Therapeutics <190A> 1. Company history The company is a bioventure established in October 2017 by six drug discovery researchers who spun out from takeda pharmaceuticals sp adr, where they were involved in the development of low molecular weight compound anticancer drugs. Four products were selected from the pipeline that was being developed during the takeda pharmaceuticals sp adr era, and a licensing agreement regarding exclusive research, development, manufacturing, and sales was signed with takeda pharmaceuticals sp adr in November of the same year.
Global Companies With at Least 50% U.S. Revenue Exposure as Trump Eyes Tariffs: BofA
US Manufacturing Index Rises To 43, Highest Since 2020
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
Greenhorn Dav : learn from mistakes n improve...U can do it
Arrayfunction OP Greenhorn Dav : Thanks for the encouragement!
So a big thanks to anyone else out there reading this too!
One thing I forgot to mention is how much I have always appreciated the Moomoo community. I can't remember a single time I had a negative interaction with another user. Reflecting now, that played a huge role in making me feel like I belong here and kept any big loss or dumb play make me hit the eject button.
Of all the places on the internet, who would have thought it'd be a group of stock traders where everyone gets along and respects one another?
Tonyco :